BAX vs. CVS: Baxter vs. CVS Health Stock Comparison
How do Baxter (BAX) and CVS Health (CVS) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Baxter (BAX) and CVS Health (CVS) both fall under the Health Care Equipment & Services industry group, but BAX is classified in Health Care Equipment & Supplies while CVS is classified in Health Care Providers & Services.
| Profile Item | BAX | CVS |
|---|---|---|
| Name | Baxter International Inc. | CVS Health Corporation Common Stock |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Providers & Services |
| GICS Sub-Industry | Health Care Equipment | Health Care Services |
| Market Capitalization | 13.34 billion USD | 107.28 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | October 27, 1981 | February 21, 1973 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | BAX | CVS |
|---|---|---|
| Total Return (1Y) | 45.72% | 11.41% |
| Total Return (3Y, Annualized) | -5.53% | 12.73% |
| Total Return (5Y, Annualized) | -17.96% | 1.70% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | BAX | CVS |
|---|---|---|
| Volatility (1Y, Annualized) | 42.31% | 34.14% |
| Beta (5Y) | 0.62 | 0.60 |
| Max Drawdown (5Y) | -80.61% | -56.79% |
| Avg. Volume (3M) | 6.53M | 8.60M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | BAX | CVS |
|---|---|---|
| Sharpe Ratio (1Y) | 0.98 | 0.21 |
| Sortino Ratio (1Y) | 1.42 | 0.28 |
Profitability
ROE (TTM)
Baxter (BAX) reports a negative ROE of -9.04%; negative ROE can reflect losses or negative shareholders’ equity, so it is harder to read as capital efficiency. Meanwhile CVS Health (CVS) reports 14.36%, ranking against industry peers normally.
BAX
Health Care Equipment & Services industry group
-9.04%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- BAX
- -9.04%
- Q1
- -10.67%
- Min
- -47.01%
CVS
Health Care Equipment & Services industry group
14.36%
- Max
- 47.61%
- CVS
- 14.36%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
Baxter (BAX) reports a negative net margin of -6.23%, usually indicating a net loss over the period. Meanwhile CVS Health (CVS) reports 2.64%, ranking against industry peers normally.
BAX
Health Care Equipment & Services industry group
-6.23%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- BAX
- -6.23%
- Q1
- -6.29%
- Min
- -28.46%
CVS
Health Care Equipment & Services industry group
2.64%
- Max
- 29.35%
- Q3
- 9.33%
- CVS
- 2.64%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Both Baxter (BAX) at 9.88% and CVS Health (CVS) at 2.72% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.
BAX
Health Care Equipment & Services industry group
9.88%
- Max
- 35.43%
- Q3
- 14.14%
- BAX
- 9.88%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
CVS
Health Care Equipment & Services industry group
2.72%
- Max
- 35.43%
- Q3
- 14.14%
- Median
- 6.81%
- CVS
- 2.72%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | BAX | CVS |
|---|---|---|
| ROE (TTM) | -9.04% | 14.36% |
| ROA (TTM) | 2.71% | 3.11% |
| Net Margin (TTM) | -6.23% | 2.64% |
| Operating Margin (TTM) | 9.88% | 2.72% |
| Gross Margin (TTM) | 33.37% | 13.72% |
Growth
Revenue Growth
Both Baxter (BAX) at 5.72% and CVS Health (CVS) at 7.85% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Only one side can be read here: CVS Health (CVS) reports EPS growth of -62.02%, ranked against its industry; Baxter (BAX) has no EPS growth figure this period.
Growth Metrics
| Metric | BAX | CVS |
|---|---|---|
| Revenue Growth (YoY) | 5.72% | 7.85% |
| Revenue Growth (3Y CAGR) | 3.79% | 7.63% |
| EPS Growth (YoY) | -- | -62.02% |
| EPS Growth (3Y CAGR) | -- | -24.73% |
Financial Strength
Current Ratio (MRQ)
Baxter (BAX) at 1.79 keeps current ratio within its industry’s typical mid-range, while CVS Health (CVS) at 0.85 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for CVS.
BAX
Health Care Equipment & Services industry group
1.79
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- BAX
- 1.79
- Q1
- 1.37
- Min
- 0.30
CVS
Health Care Equipment & Services industry group
0.85
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- CVS
- 0.85
- Min
- 0.30
Debt / Equity (MRQ)
Both Baxter (BAX) at 1.36 and CVS Health (CVS) at 0.93 lean more heavily on debt funding than most peers, landing in the higher-leverage quartile of their industries.
BAX
Health Care Equipment & Services industry group
1.36
- Max
- 1.88
- BAX
- 1.36
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
CVS
Health Care Equipment & Services industry group
0.93
- Max
- 1.88
- CVS
- 0.93
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | BAX | CVS |
|---|---|---|
| Current Ratio (MRQ) | 1.79 | 0.85 |
| Debt / Equity (MRQ) | 1.36 | 0.93 |
| Net Debt / EBITDA | 3.73 | 3.49 |
Dividends
Dividend Yield (TTM)
Both Baxter (BAX) at 0.16% and CVS Health (CVS) at 3.27% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.
BAX
Health Care Equipment & Services industry group
0.16%
- BAX
- 0.16%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
CVS
Health Care Equipment & Services industry group
3.27%
- CVS
- 3.27%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Baxter (BAX) reports payout ratio above 100% at 154.67%, meaning dividends exceeded current-period earnings and sustainability needs extra context. Meanwhile CVS Health (CVS) reports 30.89%, ranking against industry peers normally.
BAX
Health Care Equipment & Services industry group
154.67%
- BAX
- 154.67%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
CVS
Health Care Equipment & Services industry group
30.89%
- CVS
- 30.89%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | BAX | CVS |
|---|---|---|
| Dividend Yield (TTM) | 0.16% | 3.27% |
| Dividend Payout Ratio (TTM) | 154.67% | 30.89% |
Valuation
P/E Ratio (TTM)
An earnings multiple is available for just one side: CVS Health (CVS) trades at 9.74 times trailing earnings, ranked against its peers, while Baxter (BAX) has no P/E ratio this period.
BAX
Health Care Equipment & Services industry group
--
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
- BAX
- --
CVS
Health Care Equipment & Services industry group
9.74
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- CVS
- 9.74
- Min
- 4.21
P/S Ratio (TTM)
CVS Health (CVS) at 0.26 sits in the cheaper P/S ratio quartile while Baxter (BAX) at 1.15 prices around its industry’s middle — CVS costs less per dollar of sales, though read it alongside growth and margins.
BAX
Health Care Equipment & Services industry group
1.15
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- BAX
- 1.15
- Q1
- 1.10
- Min
- 0.03
CVS
Health Care Equipment & Services industry group
0.26
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- CVS
- 0.26
- Min
- 0.03
P/B Ratio (MRQ)
CVS Health (CVS) at 1.33 sits in the lower P/B ratio quartile against book while Baxter (BAX) at 2.05 is valued near its industry’s middle — CVS is cheaper on assets, though weigh it against ROE and asset quality.
BAX
Health Care Equipment & Services industry group
2.05
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- BAX
- 2.05
- Q1
- 1.73
- Min
- -1.31
CVS
Health Care Equipment & Services industry group
1.33
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- CVS
- 1.33
- Min
- -1.31
Valuation Metrics
| Metric | BAX | CVS |
|---|---|---|
| P/E Ratio (TTM) | -- | 9.74 |
| P/S Ratio (TTM) | 1.15 | 0.26 |
| P/B Ratio (MRQ) | 2.05 | 1.33 |
| Free Cash Flow Yield (TTM) | 9.16% | 11.02% |